Healthy Living Europe: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Europe.

Press releases published on November 9, 2026

Nov. 9, 2026

Zentalis Pharmaceuticals Reports Third Quarter 2026 Financial Results and Business Updates

Indeterminate GlobeNewswire

Nov. 9, 2026

Apollomics Reports First-Half 2026 Financial Results

Indeterminate GlobeNewswire

Nov. 9, 2026

OraSure Announces Third Quarter 2026 Financial Results; Strategic Execution Drives Double-Digit Year-Over-Year Growth and Margin Expansion

Indeterminate GlobeNewswire

Nov. 9, 2026

MapLight Therapeutics to Participate in Upcoming Investor Conference

Indeterminate GlobeNewswire

Nov. 9, 2026

ImageneBio Reports Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Nov. 9, 2026

Trevi Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Updates

Indeterminate GlobeNewswire

Nov. 9, 2026

PetMeds Announces Strategic Partnership with Pet Supermarket to Expand Pharmacy Offering Across Retail and Digital Channels

Indeterminate GlobeNewswire

Nov. 9, 2026

Oruka Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

Nov. 9, 2026

Harrow Announces Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Nov. 9, 2026

Globus Medical to Participate in Jefferies Global Healthcare Conference

Indeterminate GlobeNewswire

Nov. 9, 2026

MBX Biosciences Reports Third Quarter 2026 Financial Results and Corporate Highlights

Indeterminate GlobeNewswire

Nov. 9, 2026

ArriVent BioPharma Reports Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Nov. 9, 2026

POLYRIZON ADOPTS LIMITED DURATION SHAREHOLDER RIGHTS PLAN

Indeterminate GlobeNewswire

Nov. 9, 2026

Annexon Reports Third Quarter 2026 Financial Results, Business Updates and Key Anticipated Milestones

Indeterminate GlobeNewswire

Nov. 9, 2026

IRulya Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Nov. 9, 2026

SIGA Announces Retirement of Chief Scientific Officer Dennis Hruby, Ph.D.

Indeterminate GlobeNewswire

Nov. 9, 2026

Black Diamond Therapeutics to Host Webcast Highlighting Updated Silevertinib Phase 2 Data and FDA Feedback Supporting a Clear Phase 3 Path to Potential Accelerated Approval in 1L EGFR-NCM NSCLC

Indeterminate GlobeNewswire

Nov. 9, 2026

Septerna Highlights Business Progress and Reports Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Nov. 9, 2026

Xenon Reports Q3 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

Nov. 9, 2026

SIGA Reports Financial Results for Three and Nine Months Ended September 30, 2026

Indeterminate GlobeNewswire